An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Condition:   Non-Hodgkin Lymphoma, Follicular Lymphoma Interventions:   Drug: Mosunetuzumab SC;   Drug: Tiragolumab;   Drug: Atezolizumab;   Other: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19
Condition:   COVID-19 Severe Respiratory Failure Interventions:   Drug: Dexamethasone;   Drug: Low molecular weight heparin;   Drug: Anakinra 100Mg/0.67Ml Inj Syringe;   Drug: Tocilizumab;   Drug: Baricitinib;   Drug: Dornase Alfa Inhalant Product Sponsor:   Democritus University of Thrace Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2022 Category: Research Source Type: clinical trials